Australia

First patient treated in Clarity's therapeutic prostate cancer trial

Highlights * Clarity Pharmaceuticals recruits and treats its first patient in the therapeutic phase of its SAR-bisPSMA theranostic clinical trial SECuRE (NCT04868604)[1] investigating Targeted Copper Theranostics (TCTs) in patients with metastatic castrate-resistant prostate cancer (mCRPC) ...

2022-10-07 21:06 1792

Global Milk Industry Digestibility Breakthrough

--World-first Haelen technology achieves 100% fresh, natural milk that is twice as digestible BRISBANE, Australia, Oct. 4, 2022 /PRNewswire/ -- Naturo, the company behind the world-first patented 'Haelen' milk processing technology which gives fresh milk a 60-day shelf life has achieved another ...

2022-10-05 04:00 834

DetectedX to Provide Free Access to Radiology Online Learning Platform to Radiology Across Borders to Enhance Global Charity's Teaching Initiatives

Radiology Across Borders will Promote Access to DetectedX's On-Demand, Web-Based Educational Platform to Clinicians from Developing Nations to Improve Diagnostic Accuracy SYDNEY, Oct. 3, 2022 /PRNewswire/ -- DetectedX announced today that it will provide free access to its Radiology Online Learn...

2022-10-03 20:00 1605

Envato reveals significant growth in demand for its unlimited subscription service, as Envato Elements grows to become a market leader

MELBOURNE, Australia, Sept. 29, 2022 /PRNewswire/ -- Envato has revealed a 23% jump in subscribers on itsElements product, with an associated revenue increase of 33% year on year, off the back of another successful 12 months as one of the world's leading providers o...

2022-09-29 19:54 1429

JXSN#4 FLOWS HELIUM (6.5% He) TO SURFACE GALACTICA/PEGASUS

Highlights * JXSN#4 exploration well completed in Blue Star's Galactica/Pegasus prospect. * Analysis of gas obtained during drilling shows a calculated air-free gas composition of 6.5% helium in theLyons formation. * Both the upper and lower Lyons sands are gas charged with helium. * JXSN#4...

2022-09-29 12:48 1223

CONTINGENT RESOURCE CERTIFIED FOR VOYAGER FIELD

Highlights * 2C net unrisked contingent helium resource of 643 MMscf for Voyager (100% BNL). * High side (3C) net unrisked estimate of 1,228 MMscf. * First declaration of contingent resource at Voyager is in addition to existing prospective resources at Galactica/Pegasus, Enterprise, Argo, ...

2022-09-27 16:43 2474

New report offers blueprint for regulation of facial recognition technology

SYDNEY, Sept. 26, 2022 /PRNewswire/ -- A new report from the University of Technology Sydney (UTS) Human Technology Institute outlines a model law for facial recognition technology...

2022-09-27 07:33 1397

Alterity Therapeutics Announces Presentation of Wearable Sensor Data from the bioMUSE Natural History Study at the International Congress of Parkinson's Disease and Movement Disorders

- Wearable sensors strongly correlated with clinical scales on motor impairment - - bioMUSE Study Validates Use of Wearable Sensors for Alterity's Ongoing Phase 2 Clinical Trial - MELBOURNE, Australia and SAN FRANCISCO, Sept. 26, 2022 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATH...

2022-09-26 19:25 1586

Capitalise.ai and Pepperstone announce strategic partnership to enhance trading experience

Pepperstone will offer their traders an innovative AI-driven auto-trading experience Pepperstone, an award-winning CFD & Forex broker has teamed up with Capitalise.ai to offer their traders a seamless, auto-trading experience. This new partnership enables Pepperstone clients to easily analyze, a...

2022-09-21 12:01 1416

Alterity Therapeutics Receives U.S. FDA Approval for Investigational New Drug Application for ATH434 for the Treatment of Multiple System Atrophy

Regulatory Authorization Granted to Proceed with ATH434 Phase 2 Clinical Trial MELBOURNE, Australia and SAN FRANCISCO, Sept. 20, 2022 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying tr...

2022-09-20 19:25 1463

MD ANDERSON AND RADIOPHARM THERANOSTICS LAUNCH JOINT VENTURE TO DEVELOP NOVEL RADIOPHARMACEUTICALS

MELBOURNE, Australia, Sept. 13, 2022 /PRNewswire/ -- The University of Texas MD Anderson Cancer Center ('MD Anderson') and Radiopharm Theranostics Limited ('Radiopharm')(ASX: RAD) today announced the launch of Radiopharm Ventu...

2022-09-14 11:09 1243

LiveHire and Raise Recruiting Clients Wow Direct Sourcing Space

MIAMI, Sept. 12, 2022 /PRNewswire/ -- LiveHire , the globally-leading Direct Sourcing and Total Talent platform, and Raise Recruiting continue to build momentum and exceptional results in the Direct Sourcing space for contingent workforce hiring. LiveHire's Direct Sourcin...

2022-09-13 00:03 1524

LIVEHIRE AND HIREGENICS LAUNCH 3 NEW DIRECT SOURCING PROGRAMS TO PREMIER FORTUNE 500 COMPANIES

MIAMI, Sept. 8, 2022 /PRNewswire/ -- LiveHire , the globally-leading Direct Sourcing and Total Talent platform, andHireGenics , a recognized thought leader in the design, implementation, and delivery of Talent Acquisition Solutions, have succes...

2022-09-09 02:45 1750

BAI's Group CEO to speak at TMT M&A Forum USA 2022

SYDNEY, Sept. 8, 2022 /PRNewswire/ -- BAI Communications (BAI) announced today that Igor Leprince, Group Chief Executive Officer , will participate in theTMT M&A Forum USA 2022 , the ...

2022-09-08 21:00 2051

New Fortune 1000 Direct Sourcing Clients for LiveHire and Partner Broadleaf

MIAMI , Sept. 7, 2022 /PRNewswire/ -- LiveHire , the globally leading Direct Sourcing and Total Talent platform, and Broadleaf Results, a leading provider of talent acquisition and workforce management solutions, have successfully launched Direct Sourcing programs for thre...

2022-09-08 05:08 2260

Recruitment opens for Phase II trial in prostate cancer with Cu-64 SAR-Bombesin in the US

SYDNEY, Sept. 5, 2022 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity"), a clinical stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for children and adults with cancer, is pleased to announce that the US-based diagn...

2022-09-05 21:09 2684

LiveHire Announces Launch of "Thrive" Global Partner Ecosystem to Bring Together World Class Technologies and Service Providers

MIAMI, Aug. 30, 2022 /PRNewswire/ -- LiveHire Ltd. (ASX:LVH), a global software-as-a-service (SaaS) platform connecting companies and candidates, today announced the launch of the global Thrive Partner Network, bringing together the best technologies and service providers to deliver total talent ...

2022-08-30 23:02 2640

Alterity Therapeutics Launches ATH434 Phase 2 Clinical Trial for the Treatment of Patients with Multiple System Atrophy in Europe

Second region now open for enrolment for rare, rapidly progressive, neurodegenerative disease MELBOURNE, Australia and SAN FRANCISCO, Aug. 25, 2022 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing diseas...

2022-08-25 19:25 2499

LiveHire and CrintellTech Announce Strategic Integration to Automate Candidate Sourcing and Streamline the Recruiting Life-Cycle

MIAMI and CHEYENNE, Wyo., Aug. 23, 2022 /PR Newswire/ -- LiveHire Ltd. (ASX: LVH), a global software-as-a-service (SaaS)Total Talent Acquisition platform that helps companies connect with and hire the talent they need, and CrintellTech, an AI-driven recruitment intelligence platform that automate...

2022-08-23 23:03 2629

Clarity advances to cohort 3 of the CL04 trial of SARTATE™ in paediatric neuroblastoma

Highlights * Cohort 2 completed in participants with neuroblastoma who received therapy with67Cu SARTATE™ at a dose of 175MBq/kg body weight * No Dose Limiting Toxicities (DLTs) have been reported in cohort 1 and cohort 2 * Safety Review Committee (SRC) has recommended the trial continues w...

2022-08-23 21:04 2831
1 ... 12131415161718 ... 55

Week's Top Stories